Literature DB >> 25733433

Home-use faecal immunochemical testing: primary care diagnostic technology update.

Brian D Nicholson1, Matthew Thompson2, Christopher P Price1, Carl Heneghan1, Annette Plüddemann1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25733433      PMCID： PMC4337300          DOI： 10.3399/bjgp15X684229

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  11 in total

Review 1.  Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

Authors:  P Hewitson; P Glasziou; L Irwig; B Towler; E Watson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

2.  Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer.

Authors:  J Faivre; V Dancourt; B Denis; E Dorval; C Piette; Ph Perrin; J M Bidan; C Jard; S Jung; R Levillain; J Viguier; J F Bretagne
Journal:  Eur J Cancer       Date:  2012-05-07       Impact factor: 9.162

Review 3.  Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis.

Authors:  Gemma Vart; Rita Banzi; Silvia Minozzi
Journal:  Prev Med       Date:  2012-05-23       Impact factor: 4.018

4.  Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007.

Authors:  Camille Maringe; Sarah Walters; Bernard Rachet; John Butler; Tony Fields; Paul Finan; Roy Maxwell; Bjørn Nedrebø; Lars Påhlman; Annika Sjövall; Allan Spigelman; Gerda Engholm; Anna Gavin; Marianne L Gjerstorff; Juanita Hatcher; Tom B Johannesen; Eva Morris; Colleen E McGahan; Elizabeth Tracey; Donna Turner; Michael A Richards; Michel P Coleman
Journal:  Acta Oncol       Date:  2013-04-15       Impact factor: 4.089

5.  Immunological faecal occult blood testing: a discriminatory test to identify colorectal cancer in symptomatic patients.

Authors:  A Kaul; A Shah; F H Magill; S A Hawkins; P Skaife
Journal:  Int J Surg       Date:  2013-02-28       Impact factor: 6.071

Review 6.  Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis.

Authors:  Petra Jellema; Daniëlle A W M van der Windt; David J Bruinvels; Christian D Mallen; Stijn J B van Weyenberg; Chris J Mulder; Henrica C W de Vet
Journal:  BMJ       Date:  2010-03-31

7.  Well adjusted qualitative immunochemical faecal occult blood tests could be a promising alternative for inexpensive, high-quality colorectal cancer screening.

Authors:  Sha Tao; Hermann Brenner
Journal:  Eur J Cancer Prev       Date:  2013-07       Impact factor: 2.497

8.  Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.

Authors:  L Hol; M E van Leerdam; M van Ballegooijen; A J van Vuuren; H van Dekken; J C I Y Reijerink; A C M van der Togt; J D F Habbema; E J Kuipers
Journal:  Gut       Date:  2010-01       Impact factor: 23.059

Review 9.  Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT).

Authors:  James E Allison; Callum G Fraser; Stephen P Halloran; Graeme P Young
Journal:  Gut Liver       Date:  2014-03-11       Impact factor: 4.519

10.  Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme.

Authors:  Siu Hing Lo; Stephen Halloran; Julia Snowball; Helen Seaman; Jane Wardle; Christian von Wagner
Journal:  Gut       Date:  2014-05-07       Impact factor: 23.059
View more
  2 in total

1.  Disparities in outcomes among patients diagnosed with cancer in proximity to an emergency department visit.

Authors:  Nicholas Pettit; Elisa Sarmiento; Jeffrey Kline
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

2.  Variation in Direct Access to Tests to Investigate Cancer: A Survey of English General Practitioners.

Authors:  Brian D Nicholson; Jason L Oke; Peter W Rose; David Mant
Journal:  PLoS One       Date:  2016-07-22       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.